Individual Patient Expanded Access IND to Treat Polyneuropathy

NO_LONGER_AVAILABLE

Conditions studied: Polyneuropathies

In brief

This Individual Patient Expanded Access IND has been created as requested by an 58-year-old man who suffers from Polyneuropathy due to Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, and Skin abnormalities (POEMS) Syndrome. The patient will receive 8 infusions of 200 million cells every four weeks during a 28-week period to relieve the symptoms of Polyneuropathy arising due to POEMS.

Key facts

Study ID

NCT04064983

Run by

Hope Biosciences Research Foundation

Last updated by the study team

2025-09-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient diagnosed with Polyneuropathy due to POEMS Syndrome.
• Patient must have banked his stem cells at Hope Biosciences LLC.

You may not qualify if…

• The patient has any active infection requiring medications.
• The patient has any suicidal ideation during the screening visit.

Where it is running

• Hope Biosciences Stem Cell Research Foundation — Sugar Land, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.